Search results

3 items
  1. What comes next? Post-UNGASS options for 2019-2020

    • International Drug Policy Consortium (IDPC)
    29 November 2016

    The UN General Assembly Special Session (UNGASS) on drugs – held in New York in April 2016 – was hailed as an opportunity for the international community ‘to conduct a wide-ranging and open debate that considers all options’. Although the UNGASS was characterised by many shortcomings and disappointments, it was nonetheless a critical moment for global drug policy reform.

  2. UNGASS 2016: A Broken or B-r-o-a-d Consensus?

    • David Bewley-Taylor, Martin Jelsma
    05 July 2016
    Policy briefing

    A special session of the General Assembly took place in April revealing a growing divergence in the global drug policy landscape. Difficult negotiations resulted in a disappointing outcome document, perpetuating a siloed approach to drugs at the UN level. There is a clear need to realign international drug policies with the overarching 2030 Agenda and the Sustainable Development Goals, embedding the drugs issue comprehensively within the UN’s three pillars: development, human rights, and peace and security. The UNGASS process has helped to set the stage for more substantial changes in the near future, towards the next UN review in 2019.

  3. The UNGASS outcome document: Diplomacy or denialism?

    14 March 2016
    Declaration

    Drug policy experts and impacted communities from around the world express serious concerns about the preparations and already-drafted outcomes for the UN General Assembly Special Session (UNGASS) on the “world drug problem”.